This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsieh, J.-K. Articles by Demoliou-Mason, C. Search for Related Content PubMed PubMed Citation Articles by Hsieh, J.-K. Articles by Demoliou-Mason, C. Pubmed/NCBI databases Substance via MeSH Related Collections Apoptosis Cell biology/structural biology Smooth muscle proliferation and differentiation Mechanism of atherosclerosis/growth factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:636.)
© 2000 American Heart Association, Inc.

Vascular Biology

p53, p21^WAF1/CIP1, and MDM2 Involvement in Proliferation and Apoptosis in an In Vitro Model of Conditionally Immortalized Human Vascular Smooth Muscle Cells

J.-Kuang Hsieh; Dimitris Kletsas; Gerard Clunn; Alun D. Hughes; Michael Schachter; Catherine Demoliou-Mason

From Clinical Pharmacology, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, St Mary’s Hospital, and the Ludwig Institute, St Mary’s Hospital, London, UK (J.-K.H.); and the Institute of Biology, N.C.S.R. Demokritos, Athens, Greece (D.K.).

Correspondence to Dr A.D. Hughes, Clinical Pharmacology, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, St Mary’s Hospital, London W2 1NY, UK. E-mail a.hughes{at}ic.ac.uk

Abstract—Using an in vitro model of a conditionally immortalized cell line, we investigated how human vascular smooth muscle cells (VSMCs) are affected by the expression of simian virus 40 (SV40) large T antigen (LT antigen), which binds to cell cycle regulators, such as the tumor suppressor protein p53. Cells were obtained after infection of saphenous vein–derived VSMCs with a nonreplicative retroviral vector containing a temperature-sensitive (ts) mutant of SV40 LT antigen and were shown to have maintained some characteristics and responses of VSMCs. Under permissive temperature conditions (36°C), the increased rate of cell proliferation was shown to be associated with expression of LT antigen and with LT-antigen binding to and inactivation of p53. p53 inactivation failed to block apoptosis induced by serum withdrawal or by UV irradiation. Downregulation of LT-antigen expression at the nonpermissive temperature (39°C) was shown to be associated with growth arrest, increased expression of the cell cycle inhibitor p21^WAF1/CIP1, increased MDM2-promoter activity, and differential expression of MDM2 gene products, suggesting that p53-induced transcription/transactivation may be involved in VSMC cell cycle control but not necessarily apoptosis. The established SMC line HVTs-SM1 may be a useful model for the study of processes involved in myointimal hyperplasia and cellular aging, as well as for the study of cell cycle control in general.

Key Words: vascular smooth muscle • SV-40 • cell line • p53 • MDM2 • p21^WAF1/CIP1

This article has been cited by other articles:

				X. Yang, J. Wang, C. Liu, W. E. Grizzle, S. Yu, S. Zhang, S. Barnes, W. J. Koopman, J. D. Mountz, R. P. Kimberly, et al. Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts Am. J. Pathol., September 1, 2005; 167(3): 705 - 719. [Abstract] [Full Text] [PDF]

				T. Urbanek, B. Skop, K. Ziaja, T. Wilczok, R. Wiaderkiewicz, A. Pal/asz, U. Mazurek, and E. Wielgus Sapheno-Femoral Junction Pathology: Molecular Mechanism of Saphenous Vein Incompetence Clinical and Applied Thrombosis/Hemostasis, October 1, 2004; 10(4): 311 - 321. [Abstract] [PDF]

				T. Nakahara, K. Hashimoto, M. Hirano, M. Koll, C. R. Martin, and V. R. Preedy Acute and chronic effects of alcohol exposure on skeletal muscle c-myc, p53, and Bcl-2 mRNA expression Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1273 - E1281. [Abstract] [Full Text] [PDF]